Detalhe da pesquisa
1.
Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Clin Infect Dis
; 68(7): 1213-1222, 2019 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30759183
2.
Single Ad26.COV2.S booster dose following two doses of BBIBP-CorV vaccine against SARS-CoV-2 infection in adults: Day 28 results of a phase 1/2 open-label trial.
Vaccine
; 41(32): 4648-4657, 2023 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344265
3.
A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
Vaccine
; 40(15): 2352-2361, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34789403
4.
Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam.
Vaccine
; 40(26): 3621-3632, 2022 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35577631
5.
Antibody persistence 2 and 3 years after booster vaccination of adolescents with recombinant acellular pertussis monovalent aPgen or combined TdaPgen vaccines.
EClinicalMedicine
; 37: 100976, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34386749
6.
A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Lancet Infect Dis
; 18(1): 58-67, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29066131
7.
Antibody persistence after vaccination of adolescents with monovalent and combined acellular pertussis vaccines containing genetically inactivated pertussis toxin: a phase 2/3 randomised, controlled, non-inferiority trial.
Lancet Infect Dis
; 18(11): 1260-1268, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30266329
8.
Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
Hum Vaccin Immunother
; 13(1): 136-143, 2017 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27686283